Amgen Helps People Make an Informed Request to Participate in Clinical Trials

Amgen Helps People Make an Informed Request to Participate in Clinical Trials

Key Takeaways About Amgen Clinical Study Participation

  • A request to participate is an inquiry and screening step, not a promise of enrollment.
  • Each study has specific eligibility requirements, procedures, schedules, and potential risks.
  • Participants should have time to review informed consent materials, ask questions, and consider alternatives.
  • Important practical considerations include study visits, travel, costs, caregiving, work, and follow-up care.
  • Participants may decline to join or choose to leave a study.

Considering a clinical study can raise important questions about eligibility, safety, time commitments, and possible risks. Amgen provides information to help people understand what it may mean to participate in clinical trials before deciding whether to contact a study team.

Clinical study participation is voluntary. An inquiry does not guarantee that a study is open, that a person is eligible, or that participation will provide a medical benefit. People should discuss their individual circumstances with a doctor or other qualified healthcare professional.

Why Do People Consider an Amgen Clinical Study?

People explore clinical research for different reasons. Someone may have a condition with limited treatment options, want to understand research related to their health, or hope to contribute to knowledge that could help future patients. Some studies evaluate investigational medicines or approaches that may not otherwise be available. However, a clinical study is not a guaranteed substitute for standard care, and another participant’s experience does not predict an individual result.

How Does Someone Request to Participate in an Amgen Clinical Trial?

A request to participate in clinical trials is best viewed as a starting point for learning about a particular opportunity. The usual process includes the following steps:

  1. Talk with a healthcare provider. Discuss whether a study could fit the person’s diagnosis, treatment history, and current health needs.
  2. Review available studies. Recruiting status and locations can change, and an appropriate study may not be available at a given time.
  3. Consider eligibility criteria. Studies may consider age, diagnosis, medical history, prior treatment, and current health status.
  4. Complete screening. Screening may begin with questions and may involve additional assessments.
  5. Review informed consent. The materials should explain the study purpose, procedures, possible risks, possible benefits, alternatives, and participant rights.

What Happens Before an Amgen Study Begins?

Before enrollment, a person may move from an initial inquiry or referral to an eligibility review and study-specific screening. If the person may qualify and wishes to continue, they can review and sign an informed consent form. Consent is an ongoing conversation, not simply a signature. Potential participants can use the questions to ask researchers when considering a study to prepare for these discussions.

What Should Participants Expect During an Amgen Clinical Study?

Every study follows its own protocol, which describes the schedule, procedures, monitoring, and responsibilities. Depending on the study, participation may involve:

  • Study visits: Check-ins, laboratory work, physical assessments, or other health evaluations.
  • Study treatment or intervention: An investigational medicine or another approach used according to study instructions.
  • Health tracking: Questionnaires, diaries, assessments, or wearable devices that help document the participant experience.
  • Safety monitoring: Contact with the study doctor and research team, including prompt reporting of new symptoms, hospitalizations, or concerns.

Clinical studies are designed around protocols and participant protections. Before joining, people should be told about known and potential risks, possible benefits, alternatives, and their responsibilities. In the United States, research may be reviewed by an Institutional Review Board and is subject to applicable federal requirements. Participants can ask questions throughout the study, consult their own doctor, decline participation, or withdraw.

What Practical Issues Should Someone Consider?

  • Time: A study may involve a single visit or repeated visits over weeks, months, or longer.
  • Travel: Ask where activities occur, how long visits take, and whether travel reimbursement is available.
  • Costs: Ask which study-related services are covered and whether routine healthcare expenses could remain the participant’s responsibility.
  • Daily life: Consider work, school, transportation, caregiving, medication routines, and technology access.
  • Communication: Keep study contact information available and report meaningful health changes promptly.

How Can People Check Whether an Amgen Study Is Available?

Study listings can change when recruitment opens, pauses, fills, or closes. Before contacting a site, confirm the current status, location, contact instructions, and eligibility details. People can also use public study records to understand clinical research listings, but a listing does not establish eligibility or reserve a place in a study.

What Are the Main Phases of a Clinical Study?

  • Phase 1: Examines early safety, tolerability, and how an investigational medicine affects the body.
  • Phase 1/2: Combines early safety evaluation with initial assessment in people with the condition being studied.
  • Phase 2: Evaluates safety, effectiveness, doses, and treatment schedules in a larger group.
  • Phase 3: Confirms safety and effectiveness in broader populations and may support regulatory review.
  • Phase 4: Collects additional information after a medicine has been approved.

What Happens After an Amgen Clinical Study Ends?

The study team may arrange a follow-up visit or check-in and, depending on the study, help the participant transition back to standard care with their regular doctor. Results from completed research may be shared through public registries or scientific publications. Completion of a study does not mean an investigational medicine will become an approved treatment.

Questions to Ask Before Submitting a Request

Study Fit and Responsibilities

  • What is the study trying to learn, and why might it be relevant to my condition?
  • What are the eligibility requirements, visit schedule, procedures, and expected duration?
  • Where will visits occur, and what time or travel commitment is involved?

Risks, Costs, and Support

  • What risks, side effects, and possible benefits are known or anticipated?
  • Which costs are covered, and who should I contact if I have questions or concerns?
  • Can I stop participating, and how will results be shared?

Amgen’s clinical study resources are intended to make research participation easier to understand, not to replace personal medical advice. Review the details of any available study, ask the study team questions, and speak with a healthcare professional before making a decision.

Enjoyed this story? Share it!

Written By

Laura Brown

16 Articles

This author has not yet added a bio.